Close Menu
NEW YORK (GenomeWeb News) - Following its initial public offering and Euronext listing on June 27, OncoMethylome Sciences said on Friday that it has raised an additional €3.3 million through the exercise of over-allotment option by Fortis and ING, the joint lead managers in the offering.
 
OncoMethylome granted the option on up to 440,000 new shares, at the IPO price of €7.5 per share.
 
As a result, the company's proceeds from the IPO total €25.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.